Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CI vs MRNA✓SelectedUSD · MRNACI vs MRNA performance historyLatest closeAs of+1.06%11/16
Stock and ETF performance explorer

CI vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+62.0%
MRNA return
+878.5%
Excess return
-816.5%
Maximum drawdown
-41.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.1%-3.6%+4.7%+1.1%
7D+1.5%-20.0%+21.5%+1.5%
30D-0.7%-1.3%+0.5%-0.7%
3M+6.8%+240.0%-233.2%+7.4%
6M+6.4%+339.0%-332.6%+7.2%
YTD+10.9%+630.0%-619.1%+12.0%
1Y+13.8%+769.1%-755.2%+15.1%
3Y+12.7%+181.2%-168.5%+13.9%
5Y+51.3%-8.1%+59.4%+51.5%
All+62.0%+878.5%-816.5%+62.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling